Clinical Trials on Advanced Fibrosis
Total 11330 results
-
Boehringer IngelheimCompletedPulmonary FibrosisSpain, Belgium, Canada, Germany, China, United Kingdom, Australia, Ireland, Italy, Mexico, Netherlands, Portugal, Argentina, France, Russian Federation, Greece, Czechia, Brazil, Bulgaria, Chile, Hungary
-
University of Alabama at BirminghamPulmonary Fibrosis FoundationCompletedIdiopathic Pulmonary FibrosisUnited States
-
Alicia GerkePulmonary Fibrosis FoundationTerminatedIdiopathic Pulmonary Fibrosis | Pulmonary FibrosisUnited States
-
University of NottinghamGlaxoSmithKline; McMaster University; Medical Research Council; CRAFT ConsortiumCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
University of PittsburghUniversity of Pennsylvania; Milton S. Hershey Medical Center; Temple University; Geisinger ClinicCompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Germany, Peru, Mexico, Poland, France, Italy, United Kingdom, Australia, Canada, Spain, Japan
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Denmark, France, Germany, Italy, Netherlands, Spain
-
Clinica Universidad de Navarra, Universidad de...CompletedIdiopathic Pulmonary FibrosisSpain
-
Newcastle-upon-Tyne Hospitals NHS TrustNewcastle UniversityCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Germany
-
MedImmune LLCTerminatedIdiopathic Pulmonary FibrosisUnited States, Australia, Korea, Republic of, Peru, Canada, Israel
-
Boehringer IngelheimApproved for marketingIdiopathic Pulmonary FibrosisUnited States
-
GlaxoSmithKlineCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Peking Union Medical College HospitalStanford UniversityUnknownIdiopathic Pulmonary FibrosisChina
-
AstraZenecaMedImmune LLCCompleted
-
Hoffmann-La RocheWithdrawnIdiopathic Pulmonary Fibrosis
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Australia, Belgium, China, Czech Republic, France, Germany, India, Ireland, Israel, Italy, Japan, United Kingdom
-
University of East AngliaCompleted
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited Kingdom, Belgium, Germany, France, Sweden, Austria, Denmark, Italy
-
SanofiCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Chile, Mexico
-
University of PittsburghWithdrawnIdiopathic Pulmonary FibrosisUnited States
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Schön Klinik Berchtesgadener LandCompletedIdiopathic Pulmonary FibrosisGermany
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaTerminatedIdiopathic Pulmonary FibrosisItaly
-
Boehringer IngelheimCompletedPulmonary FibrosisArgentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan and more
-
Royal Brompton & Harefield NHS Foundation TrustGlaxoSmithKlineCompleted
-
ActelionWithdrawnIdiopathic Pulmonary Fibrosis
-
Kasiak Research Pvt. Ltd.UnknownIdiopathic Pulmonary FibrosisIndia
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisBelgium, France, Germany, Israel, Spain, United States, Switzerland, Colombia, Mexico, Italy, Czech Republic, Australia, Canada, Austria, Poland, United Kingdom, Argentina, Netherlands, Peru, Ireland, Brazil, Chile
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedIdiopathic Pulmonary FibrosisUnited States
-
Beijing Kawin Technology Share-Holding Co., Ltd.UnknownIdiopathic Pulmonary FibrosisChina
-
InterMuneCompletedIdiopathic Pulmonary FibrosisUnited States
-
University of California, Los AngelesUnknownMinocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot StudyIdiopathic Pulmonary FibrosisUnited States
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis FoundationNot yet recruitingCystic Fibrosis in ChildrenUnited States
-
Chris GossMedical University of South Carolina; University of Washington; Cystic Fibrosis...RecruitingCystic Fibrosis | Cystic Fibrosis Pulmonary ExacerbationUnited States, Canada
-
The Hospital for Sick ChildrenCanadian Cystic Fibrosis FoundationCompletedCystic Fibrosis Pulmonary ExacerbationCanada
-
AceragenWithdrawnCystic Fibrosis | Cystic Fibrosis Pulmonary ExacerbationUnited States
-
Indiana UniversityCompleted
-
University of WashingtonMedical University of South Carolina; Cystic Fibrosis FoundationCompletedCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Lung InfectionUnited States
-
Centre Hospitalier Intercommunal CreteilNot yet recruitingEnvironmental Exposure | Cystic Fibrosis, Pulmonary | Exhaled Breath Condansate
-
National Taiwan University HospitalUnknownPeritoneal FibrosisTaiwan
-
West Park Healthcare CentreRecruitingLung; Disease, Interstitial, With FibrosisCanada
-
Indalo Therapeutics, Inc.TerminatedIdiopathic Pulmonary Fibrosis | Healthy VolunteersUnited Kingdom
-
InterMuneTerminatedIdiopathic Pulmonary Fibrosis | Pulmonary Fibrosis | Lung DiseaseUnited States
-
InterMuneTerminatedIdiopathic Pulmonary Fibrosis | Pulmonary Fibrosis | Lung DiseaseUnited States
-
Medtronic - MITGRegistrat-MapiCompletedFertility Disorders | Uterine FibroidsFrance
-
BiosencyRennes University Hospital; Air de Bretagne; Association Fibroses Pulmonaires...RecruitingIdiopathic Pulmonary FibrosisFrance
-
Boehringer IngelheimNot yet recruitingIdiopathic Pulmonary Fibrosis